Amgen Receives CHMP Positive Opinion For IMLYGIC™ (Talimogene Laherparepvec)
October 23, 2015 at 07:28 AM EDT
Amgen (NASDAQ: AMGN) today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the ...
